reMYND's Contract Research Organization (CRO) is a trusted research partner specialized in the pre-clinical in-vivo testing of all experimental Alzheimer treatments. By contributing our extensive expertise and experience we are helping our clients in understanding as fast as possible the therapeutic in-vivo effects of their lead preclinical Alzheimer therapies.
reMYND’s proprietary Alzheimer mouse models are based on the human clinical APP-London allele APP[V717I]– a preferred model for anti-BACE1 approaches – either alone or in combination with the human clinical PS1[A246E] allele, now extended to a TAU[P301L] and APPxTAU model, the latter combining both amyloid plaque and tau tangle pathology.
High client satisfaction is our key driver, committing us to excel in communication, dedication and flexibility
An Tanghe, PhD
Manager Contract Research
Gaston Geenslaan 1
Tel: +32 16 75 14 22
Fax: +32 16 75 14 21